News

A new study led by scientists at the Babraham Institute in Cambridge, UK identifies Tia1 as a hair-trigger protein that stops our body’s defences from turning against us.

A new bio-ink that may support a more efficient and inexpensive fabrication of human tissues and organs has been created by researchers at UBC’s Okanagan campus.

Endomag can now use Magseed, an accurate marker for surgeons to use during breast cancer removal surgery.

Scientists at The Scripps Research Institute (TSRI) have made a discovery that could speed efforts to develop a successful HIV vaccine.

The source of spontaneous, high-amplitude bursts of activity seen in the brains of preterm babies, which are vital for healthy development, has been identified by a team led by researchers at UCL and King’s College London.

Researchers at the Helmholtz Zentrum München have developed a new method for reconstructing continuous biological processes, such as disease progression, using image data.

A Northeastern research team has developed new technology that optimizes DNA sequencing using nanophysics and electric currents.

This represents an almost 10 per cent increase on the 80,000 genomes currently in genome repositories.

The new study reports the results from two Phase III clinical trials evaluating the efficacy of mepolizumab, an antibody treatment that reduces the number of eosinophils in the blood, in moderate to severe treatment-resistant eosinophilic COPD.

Professor Toshihide Yamashita said" RTN4 is a promising candidate gene for schizophrenia because it is located at chromosome 22q11.2, a hotspot for schizophrenia”.